Lexeo Therapeutics CFO Micah Zajic's 2023 pay jumps 205% to $3.1M
Lexeo Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 26, 2024
Lexeo Therapeutics reported fiscal year 2023 executive compensation information on April 26, 2024.
In 2023, four executives at Lexeo Therapeutics received on average a compensation package of $2.3M, a 158% increase compared to previous year.
Average pay of disclosed executives at Lexeo Therapeutics
Micah Zajic, Chief Financial Officer, received $3.1M in total. 80% of Zajic's compensation, or $2.5M, was in option awards. Zajic also received $166K in bonus, $423K in salary, as well as $11K in other compensation.
Eric Adler, Chief Medical Officer, received a compensation package of $3M. 80% of the compensation package, or $2.4M, was in option awards.
R. Nolan Townsend, Chief Executive Officer, earned $1.7M in 2023, a 146% increase compared to previous year.
Jenny R. Robertson, Chief Business and Legal Officer, received $1.3M in 2023, which increases by 22% compared to 2022.
Related executives
You may also like
Source: SEC filing on April 26, 2024.